Anna Mazur
Researcher
Also affiliated: Wrocław University of Science and Technology (2016); University of Helsinki (2009); Universität Hamburg (2003); Washington University in St. Louis (2009); University Medical Center Hamburg-Eppendorf (2003); Cancer Research Center (2011); Winthrop Rockefeller Foundation (2011–2012); Institute on Aging (2024); Arkansas Department of Health (2009); Marshall University (2024)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Anna Mazur's research focuses on understanding and mitigating the toxicity of cryoprotectants, substances used to preserve biological tissues at low temperatures. Her work investigates how biological systems can be manipulated to reduce this toxicity. Recent publications in 2024 highlight the potential for inducing stress response pathways to significantly lower cryoprotectant toxicity. Mazur's scholarship metrics include an h-index of 7, with 15 total publications and 561 citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Robert J. Shmookler Reis, Srinivas Ayyadevara, and Nirjal Mainali, co-authoring two publications with each.
Metrics
- h-index: 7
- Publications: 15
- Citations: 562
Selected Publications
-
Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity (2024)
-
Cleavage of Type I Collagen by Fibroblast Activation Protein-α Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion (2016)
-
Fibroblast‐Macrophage Interactions: Regulation by Modification of Extracellular Matrix (2015)
-
Fibroblast Activation Protein-α (2012)
-
Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions (2011)
-
Comparative characterization of UDP‐glucuronic acid (UDP‐GlcUA) binding‐site directed inhibitors with human UGT2B7 and 1A10. (2009)
-
The glucuronidation of native and oxidized estrogens can be effectively inhibited by compounds structurally related to UDP‐glucuronic acid in human recombinant UGT1A10 (2009)
-
Characterization of mutation in the <sup>395</sup> DQxD <sup>398</sup> motif of the glucuronic acid binding site in human UGT1A6: Comparison to UGT1A10 (2009)
-
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids (2009)
-
Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans (2009)
Collaboration Network
Top Collaborators
- Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity
- Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity
- Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity
- Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity
- Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity
- Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity
- Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity
Similar Researchers
Based on overlapping research topics